February 16, 2017
Vectura achieves royalty cap from GSK’s respiratory products
Vectura Group has reached a royalty cap on net sales of £9 million from selling GSK’s respiratory Ellipta products in 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Skypharma
March 22, 2016
Skypharma apply for listing 1,1M £1.00 ordinary shares of to trade on LSE
Skyepharma has made an application to the UK Listing Authority (UKLA) and the London Stock Exchange for the listing of 1,100,000…